Company Description
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally.
The company operates in two segments, Engineering and Other Scientific, and Environmental and Health.
It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, metallurgical and corrosion engineering polymer and chemistry, thermal sciences, and vehicle engineering.
The company also offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences.
In addition, it provides proactive and reactive product safety, litigation support, and technical, regulatory services.
It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors.
The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998.
The company was founded in 1967 and is headquartered in Menlo Park, California.
| Country | United States |
| Founded | 1967 |
| IPO Date | Aug 17, 1990 |
| Industry | Engineering & Construction |
| Sector | Industrials |
| Employees | 1,212 |
| CEO | Catherine Corrigan |
Contact Details
Address: 149 Commonwealth Drive Menlo Park, California 94025 United States | |
| Phone | 650 326 9400 |
| Website | exponent.com |
Stock Details
| Ticker Symbol | EXPO |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | February - January |
| Reporting Currency | USD |
| CIK Code | 0000851520 |
| CUSIP Number | 30214U102 |
| ISIN Number | US30214U1025 |
| Employer ID | 77-0218904 |
| SIC Code | 8742 |
Key Executives
| Name | Position |
|---|---|
| Dr. Catherine Ford Corrigan P.E., Ph.D. | Chief Executive Officer and Director |
| Richard L. Schlenker Jr. | Executive Vice President and Corporate Secretary |
| Dr. Maureen T. F. Reitman F.S.P.E., P.E., Sc.D. | Group Vice President |
| Dr. Joseph Rakow Ph.D. | Group Vice President |
| Dr. Joseph Sala Ph.D. | Group Vice President |
| Dr. Bradley A. James FASM, P.E., Ph.D. | Group Vice President |
| Dr. Richard Reiss Sc.D. | Group Vice President |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 30, 2026 | 8-K | Current Report |
| Apr 29, 2026 | SCHEDULE 13G | Filing |
| Apr 29, 2026 | SCHEDULE 13G | Filing |
| Apr 21, 2026 | ARS | Filing |
| Apr 20, 2026 | DEF 14A | Other definitive proxy statements |
| Apr 15, 2026 | 144 | Filing |
| Apr 6, 2026 | 8-K | Current Report |
| Mar 26, 2026 | SCHEDULE 13G/A | Filing |
| Mar 16, 2026 | 144 | Filing |
| Feb 27, 2026 | 10-K | Annual Report |